Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 8
2000 4
2001 4
2002 6
2003 5
2004 2
2006 1
2007 1
2008 2
2009 2
2010 1
2012 1
2013 1
2016 2
2017 1
2018 1
2020 6
2021 12
2022 12
2023 11
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group. Avendaño-Solá C, et al. Among authors: perez olmeda m. J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740. J Clin Invest. 2021. PMID: 34473652 Free PMC article. Clinical Trial.
SARS-CoV-2 seroprevalence in Spain - Authors' reply.
Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Pérez-Olmeda M, Yotti R; ENE-COVID Study Group. Pollán M, et al. Among authors: perez olmeda m. Lancet. 2020 Nov 7;396(10261):1484-1485. doi: 10.1016/S0140-6736(20)32266-2. Lancet. 2020. PMID: 33160561 Free PMC article. No abstract available.
Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
Borobia AM, Carcas AJ, Pérez-Olmeda M, Castaño L, Bertran MJ, García-Pérez J, Campins M, Portolés A, González-Pérez M, García Morales MT, Arana-Arri E, Aldea M, Díez-Fuertes F, Fuentes I, Ascaso A, Lora D, Imaz-Ayo N, Barón-Mira LE, Agustí A, Pérez-Ingidua C, Gómez de la Cámara A, Arribas JR, Ochando J, Alcamí J, Belda-Iniesta C, Frías J; CombiVacS Study Group. Borobia AM, et al. Among authors: perez olmeda m. Lancet. 2021 Jul 10;398(10295):121-130. doi: 10.1016/S0140-6736(21)01420-3. Epub 2021 Jun 25. Lancet. 2021. PMID: 34181880 Free PMC article. Clinical Trial.
West Nile virus emergence in humans in Extremadura, Spain 2020.
Macias A, Martín P, Pérez-Olmeda M, Fernández-Martínez B, Gómez-Barroso D, Fernández E, Ramos JM, Herrero L, Rodríguez S, Delgado E, Sánchez-Seco MP, Galán M, Corbacho AJ, Jimenez M, Montero-Peña C, Valle A, Vázquez A. Macias A, et al. Among authors: perez olmeda m. Front Cell Infect Microbiol. 2023 Jul 4;13:1155867. doi: 10.3389/fcimb.2023.1155867. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37469597 Free PMC article.
Regular Humoral and Cellular Immune Responses in Individuals with Chronic Myeloid Leukemia Who Received a Full Vaccination Schedule against COVID-19.
Rodríguez-Mora S, Corona M, Solera Sainero M, Mateos E, Torres M, Sánchez-Menéndez C, Casado-Fernández G, García-Pérez J, Pérez-Olmeda M, Murciano-Antón MA, López-Jiménez J, Coiras M, García-Gutiérrez V. Rodríguez-Mora S, et al. Among authors: perez olmeda m. Cancers (Basel). 2023 Oct 20;15(20):5066. doi: 10.3390/cancers15205066. Cancers (Basel). 2023. PMID: 37894433 Free PMC article.
Comparative evaluation of assays for IgM detection of rubella and measles infections.
Pérez Olmeda M, Balfagón P, Camacho J, Dafouz D, de la Fuente J, Murillo MÁ, Muñoz JL, Fernández García A, Sanz JC, de Ory F. Pérez Olmeda M, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jan;40(1):22-27. doi: 10.1016/j.eimce.2020.06.020. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 34991849
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
García-Pérez J, Borobia AM, Pérez-Olmeda M, Portolés A, Castaño L, Campins-Artí M, Bertrán MJ, Bermejo M, Arribas JR, López A, Ascaso-Del-Rio A, Arana-Arri E, Fuentes Camps I, Vilella A, Cascajero A, García-Morales MT, Castillo de la Osa M, Pérez Ingidua C, Lora D, Jiménez-Santana P, Pino-Rosa S, Gómez de la Cámara A, De La Torre-Tarazona E, Calonge E, Cruces R, Belda-Iniesta C, Alcamí J, Frías J, Carcas AJ, Díez-Fuertes F; CombiVacS Study Group. García-Pérez J, et al. Among authors: perez olmeda m. iScience. 2024 Aug 14;27(9):110728. doi: 10.1016/j.isci.2024.110728. eCollection 2024 Sep 20. iScience. 2024. PMID: 39286494 Free PMC article.
86 results